ONC – BeOne Medicines Ltd ADR

ONC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.89

Margin Of Safety %

-2

Put/Call OI Ratio

0.78

EPS Next Q Diff

-0.23

EPS Last/This Y

-1.47

EPS This/Next Y

3.12

Price

280.6

Target Price

414.15

Analyst Recom

1.25

Performance Q

1.06

Upside

-44.0%

Beta

0.5

Ticker: ONC

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	ONC	287.76	1.15	0.44	1644
2026-06-02	ONC	274.5	1.16	3.26	1671
2026-06-03	ONC	279.26	1.17	7.00	1687
2026-06-04	ONC	279.86	1.19	1.67	1703
2026-06-05	ONC	270.08	1.19	0.30	1716
2026-06-08	ONC	270.66	1.16	0.23	1769
2026-06-09	ONC	268.06	1.18	0.04	1761
2026-06-10	ONC	263.38	1.04	0.03	1677
2026-06-11	ONC	260.33	0.76	4.91	1977
2026-06-12	ONC	264.48	0.76	0.58	1976
2026-06-15	ONC	268.47	0.76	0.00	1970
2026-06-16	ONC	264.21	0.75	0.39	1979
2026-06-17	ONC	262.68	0.71	1.67	1936
2026-06-18	ONC	270.61	0.70	0.19	1932
2026-06-22	ONC	272.14	0.74	0.78	1821
2026-06-23	ONC	276.08	0.75	6.89	1821
2026-06-24	ONC	277.39	0.79	0.19	1877
2026-06-25	ONC	275.31	0.78	0.29	1896
2026-06-26	ONC	279.99	0.78	0.25	1904
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	ONC	288.34	84.4	78.6	6.69
2026-06-01	ONC	279.52	89.6	41.4	6.69
2026-06-02	ONC	275.05	89.6	54.0	6.69
2026-06-03	ONC	278.60	89.6	86.7	6.69
2026-06-04	ONC	280.66	89.6	80.4	6.69
2026-06-05	ONC	270.00	89.6	60.3	6.69
2026-06-08	ONC	270.10	89.6	82.9	6.62
2026-06-09	ONC	268.53	89.6	83.2	6.62
2026-06-10	ONC	263.74	89.6	83.9	6.62
2026-06-11	ONC	260.80	89.6	57.2	6.62
2026-06-12	ONC	264.94	89.6	115.1	6.62
2026-06-15	ONC	264.48	89.6	98.2	6.59
2026-06-16	ONC	264.75	89.6	86.9	6.59
2026-06-17	ONC	261.52	89.6	79.0	6.59
2026-06-18	ONC	270.51	89.6	137.9	6.59
2026-06-22	ONC	270.92	89.6	96.6	6.59
2026-06-23	ONC	275.04	89.6	118.6	6.59
2026-06-24	ONC	276.92	89.6	127.7	6.59
2026-06-25	ONC	276.44	89.6	123.0	6.59
2026-06-26	ONC	280.60	89.6	80.3	6.59
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	ONC	-18.19	0.37	1.03
2026-06-02	ONC	-17.86	-1.64	1.03
2026-06-03	ONC	-17.86	-1.64	1.03
2026-06-04	ONC	-17.88	-1.64	1.03
2026-06-05	ONC	-17.88	-1.64	1.03
2026-06-08	ONC	-17.88	-1.54	1.03
2026-06-09	ONC	-17.88	-1.54	1.03
2026-06-10	ONC	-17.88	-1.54	1.07
2026-06-11	ONC	-18.99	-1.54	1.07
2026-06-12	ONC	-18.99	-1.54	1.07
2026-06-15	ONC	-18.90	-1.67	1.07
2026-06-16	ONC	-19.46	-1.67	1.07
2026-06-17	ONC	-19.46	-1.67	1.07
2026-06-18	ONC	-5.09	-1.67	1.07
2026-06-22	ONC	-6.23	-1.65	1.07
2026-06-23	ONC	-6.23	-1.65	1.07
2026-06-24	ONC	-6.23	-1.65	1.07
2026-06-25	ONC	-6.23	-1.65	1.07
2026-06-26	ONC	-7.18	-1.65	0.89
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.96

Avg. EPS Est. Current Quarter

1.59

Avg. EPS Est. Next Quarter

1.73

Insider Transactions

-7.18

Institutional Transactions

-1.65

Beta

0.5

Average Sales Estimate Current Quarter

1594

Average Sales Estimate Next Quarter

1667

Fair Value

276.18

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

34.2

Max Drawdown 5-Year %

-70

Target Price

414.15

P/E

62.46

Forward P/E

29.13

PEG

0.41

P/S

4.97

P/B

6.53

P/Free Cash Flow

25.62

EPS

4.48

Average EPS Est. Cur. Y

6.59

EPS Next Y. (Est.)

9.72

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.94

Relative Volume

1.37

Return on Equity vs Sector %

-16.6

Return on Equity vs Industry %

-0.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

80.3

◆ ONC Healthcare

$279.89

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

17/25

Volume

3/15

Valuation

15/20

TP/AR

2/10

Options

5/10

RSI

50.7

Range 1M

48.7%

Sup Dist

2.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

28/30

Estimates

5/20

Inst/Vol

4/15

Options

6/10

EPS Yr

155.9%

EPS NY

42.8%

52W%

26.6%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +20% upside

Quality

14/30

Valuation

9/30

Growth

20/25

Stability

5/10

LT Trend

1/5

Upside

+20%

Quality

MoS

-2%

ONC — P/E HistoricalBiotechnology

BeOne Medicines Ltd.

Sector: Healthcare

Industry: Biotechnology

Employees: 12000

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK targeting chimeric degradation activation compound active against wild type and mutant BTK; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187 and BG-C0902, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.

ONC

Latest News

—

Caricamento notizie per ONC…

stock quote shares ONC – BeOne Medicines Ltd ADR Stock Price stock today

news today ONC – BeOne Medicines Ltd ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ONC – BeOne Medicines Ltd ADR yahoo finance google finance

stock history ONC – BeOne Medicines Ltd ADR invest stock market

stock prices ONC premarket after hours

ticker ONC fair value insiders trading

AMRZ – Amrize Ltd

AMRZ — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.71

Margin Of Safety %

-4

Put/Call OI Ratio

0.56

EPS Next Q Diff

1.33

EPS Last/This Y

0.55

EPS This/Next Y

0.43

Price

56.01

Target Price

63.73

Analyst Recom

1.88

Performance Q

2.22

Upside

-17.7%

Beta

-0.08

Ticker: AMRZ

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	AMRZ	54.33	0.67	0.27	24901
2026-06-02	AMRZ	54.36	0.66	0.18	25157
2026-06-03	AMRZ	53.84	0.66	1.43	25153
2026-06-04	AMRZ	54.36	0.66	0.00	25167
2026-06-05	AMRZ	53.6	0.52	0.23	29217
2026-06-08	AMRZ	50.79	0.53	0.59	29072
2026-06-09	AMRZ	52.69	0.53	1.08	29109
2026-06-10	AMRZ	50.5	0.52	0.46	29111
2026-06-11	AMRZ	52.3	0.52	0.60	29116
2026-06-12	AMRZ	53.19	0.52	0.06	29142
2026-06-15	AMRZ	54.04	0.52	0.01	29162
2026-06-16	AMRZ	55.62	0.54	0.24	28708
2026-06-17	AMRZ	54.26	0.49	0.05	33345
2026-06-18	AMRZ	55.38	0.49	0.14	33438
2026-06-22	AMRZ	53.59	0.58	0.09	27057
2026-06-23	AMRZ	52.81	0.56	0.18	27869
2026-06-24	AMRZ	54.5	0.56	0.54	27942
2026-06-25	AMRZ	55.87	0.56	0.10	28022
2026-06-26	AMRZ	55.9	0.56	0.33	28187
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	AMRZ	54.15	-0.4	376.9	2.69
2026-06-01	AMRZ	53.84	2.1	329.0	2.69
2026-06-02	AMRZ	54.34	2.1	364.6	2.69
2026-06-03	AMRZ	53.37	2.1	284.4	2.69
2026-06-04	AMRZ	54.36	2.1	350.5	2.69
2026-06-05	AMRZ	53.59	2.1	316.1	2.69
2026-06-08	AMRZ	50.79	2.1	226.4	2.69
2026-06-09	AMRZ	52.69	2.1	385.0	2.69
2026-06-10	AMRZ	50.51	2.1	308.7	2.69
2026-06-11	AMRZ	52.31	2.1	362.9	2.69
2026-06-12	AMRZ	53.18	2.1	411.7	2.69
2026-06-15	AMRZ	54.02	2.1	381.2	2.69
2026-06-16	AMRZ	55.63	2.1	378.1	2.69
2026-06-17	AMRZ	54.26	2.1	295.6	2.69
2026-06-18	AMRZ	55.35	2.1	300.1	2.69
2026-06-22	AMRZ	53.59	2.2	249.1	2.69
2026-06-23	AMRZ	52.80	2.2	286.1	2.69
2026-06-24	AMRZ	54.54	2.2	372.1	2.69
2026-06-25	AMRZ	55.89	2.2	357.4	2.69
2026-06-26	AMRZ	56.01	1.5	349.0	2.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	AMRZ	0.22	-1.50	1.64
2026-06-02	AMRZ	0.22	-3.41	1.64
2026-06-03	AMRZ	0.22	-3.41	1.64
2026-06-04	AMRZ	0.22	-3.41	1.64
2026-06-05	AMRZ	0.22	-3.41	1.64
2026-06-08	AMRZ	0.22	-3.46	1.64
2026-06-09	AMRZ	0.22	-3.46	1.64
2026-06-10	AMRZ	0.22	-3.46	1.49
2026-06-11	AMRZ	0.22	-3.46	1.49
2026-06-12	AMRZ	0.22	-3.46	1.49
2026-06-15	AMRZ	0.22	-3.44	1.49
2026-06-16	AMRZ	0.22	-3.44	1.49
2026-06-17	AMRZ	0.22	-3.44	1.49
2026-06-18	AMRZ	0.22	-3.44	1.49
2026-06-22	AMRZ	0.22	-3.44	1.49
2026-06-23	AMRZ	0.22	-3.44	1.49
2026-06-24	AMRZ	0.22	-3.44	1.49
2026-06-25	AMRZ	0.22	-3.44	1.49
2026-06-26	AMRZ	0.22	-3.44	1.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

1.01

Avg. EPS Est. Next Quarter

1.17

Insider Transactions

0.22

Institutional Transactions

-3.44

Beta

-0.08

Average Sales Estimate Current Quarter

3322

Average Sales Estimate Next Quarter

3802

Fair Value

53.81

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

15.1

Max Drawdown 5-Year %

Target Price

63.73

P/E

26.73

Forward P/E

17.47

PEG

0.87

P/S

2.59

P/B

2.36

P/Free Cash Flow

23.41

EPS

2.09

Average EPS Est. Cur. Y

2.69

EPS Next Y. (Est.)

3.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.7

Relative Volume

0.98

Return on Equity vs Sector %

-7.4

Return on Equity vs Industry %

-15.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

349

◆ AMRZ Basic Materials

$55.87

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

10/25

Volume

7/15

Valuation

11/20

TP/AR

1/10

Options

5/10

RSI

Range 1M

77.7%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

14/30

Estimates

2/20

Inst/Vol

3/15

Options

8/10

EPS Yr

31.1%

EPS NY

14%

52W%

52.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +13.2% upside

Quality

7/30

Valuation

6/30

Growth

11/25

Stability

3/10

LT Trend

3/5

Upside

+13.2%

Quality

MoS

-4%

AMRZ — P/E HistoricalBuilding Materials

Amrize Ltd

Sector: Basic Materials

Industry: Building Materials

Employees: 19000

Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.

AMRZ

Latest News

—

Caricamento notizie per AMRZ…

stock quote shares AMRZ – Amrize Ltd Stock Price stock today

news today AMRZ – Amrize Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRZ – Amrize Ltd yahoo finance google finance

stock history AMRZ – Amrize Ltd invest stock market

stock prices AMRZ premarket after hours

ticker AMRZ fair value insiders trading

ADCT – Adc Therapeutics SA

ADCT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

6.16

Margin Of Safety %

Put/Call OI Ratio

0.02

EPS Next Q Diff

-0.01

EPS Last/This Y

0.27

EPS This/Next Y

0.19

Price

1.04

Target Price

4.7

Analyst Recom

2.33

Performance Q

-74.24

Upside

-3,702.9%

Beta

1.96

Ticker: ADCT

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	ADCT	3.4	0.06	0.00	3851
2026-06-02	ADCT	3.17	0.08	0.02	4048
2026-06-03	ADCT	3.08	0.07	0.01	4259
2026-06-04	ADCT	1.32	0.11	0.22	4655
2026-06-05	ADCT	1	0.07	0.04	4872
2026-06-08	ADCT	0.9776	0.05	0.00	4839
2026-06-09	ADCT	1.15	0.05	1.57	4898
2026-06-10	ADCT	1.105	0.05	0.00	4879
2026-06-11	ADCT	1.07	0.05	5.00	4878
2026-06-12	ADCT	1.055	0.05	1.50	4879
2026-06-15	ADCT	1.06	0.05	0.02	4881
2026-06-16	ADCT	0.9907	0.05	0.00	4752
2026-06-17	ADCT	1.095	0.04	0.00	4734
2026-06-18	ADCT	1.085	0.04	999.99	4743
2026-06-22	ADCT	1.09	0.02	0.00	3467
2026-06-23	ADCT	1.155	0.02	0.00	3472
2026-06-24	ADCT	1.06	0.02	0.00	3472
2026-06-25	ADCT	1.045	0.02	0.00	3598
2026-06-26	ADCT	1.035	0.02	0.00	3601
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	ADCT	3.40	-	-	-0.85
2026-06-01	ADCT	3.40	-	-	-0.85
2026-06-02	ADCT	3.16	-	-	-0.85
2026-06-03	ADCT	3.08	-	-	-0.85
2026-06-04	ADCT	1.32	-	-	-0.85
2026-06-05	ADCT	1.02	-	-	-0.85
2026-06-08	ADCT	0.98	-	-	-0.84
2026-06-09	ADCT	1.11	-	-	-0.84
2026-06-10	ADCT	1.10	-	-	-0.84
2026-06-11	ADCT	1.07	-	-	-0.84
2026-06-12	ADCT	1.05	-	-	-0.85
2026-06-15	ADCT	1.06	-	-	-0.85
2026-06-16	ADCT	0.99	-	-	-0.85
2026-06-17	ADCT	1.10	-	-	-0.85
2026-06-18	ADCT	1.09	-	-	-0.85
2026-06-22	ADCT	1.10	-	-	-0.85
2026-06-23	ADCT	1.15	-	-	-0.85
2026-06-24	ADCT	1.07	-	-	-0.85
2026-06-25	ADCT	1.05	-	-	-0.85
2026-06-26	ADCT	1.04	-	-	-0.85
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	ADCT	-16.69	1.52	5.87
2026-06-02	ADCT	-16.69	1.45	5.87
2026-06-03	ADCT	-16.69	1.45	5.87
2026-06-04	ADCT	-16.69	1.45	5.87
2026-06-05	ADCT	-16.69	1.45	5.87
2026-06-08	ADCT	-16.69	1.46	5.90
2026-06-09	ADCT	-16.52	1.46	5.90
2026-06-10	ADCT	-16.52	1.46	6.22
2026-06-11	ADCT	-16.52	1.46	6.22
2026-06-12	ADCT	-16.52	1.46	6.22
2026-06-15	ADCT	-16.52	1.42	6.22
2026-06-16	ADCT	-16.52	1.42	6.22
2026-06-17	ADCT	-16.52	1.42	6.22
2026-06-18	ADCT	-16.52	1.42	6.22
2026-06-22	ADCT	-16.52	1.42	6.22
2026-06-23	ADCT	-16.52	1.42	6.22
2026-06-24	ADCT	-16.52	1.42	6.22
2026-06-25	ADCT	-16.52	1.42	6.22
2026-06-26	ADCT	-16.52	1.42	6.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.22

Insider Transactions

-16.52

Institutional Transactions

1.42

Beta

1.96

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.8

Max Drawdown 5-Year %

-98.5

Target Price

4.7

P/E

Forward P/E

PEG

P/S

1.64

P/B

P/Free Cash Flow

EPS

-1.05

Average EPS Est. Cur. Y

-0.85

EPS Next Y. (Est.)

-0.66

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-173.02

Relative Volume

2.56

Return on Equity vs Sector %

35.9

Return on Equity vs Industry %

52.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ ADCT Healthcare

$1.02

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

11/25

Volume

3/15

Valuation

12/20

TP/AR

1/10

Options

6/10

RSI

20.3

Range 1M

8.4%

Sup Dist

2.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

14/30

Estimates

2/20

Inst/Vol

6/15

Options

7/10

EPS Yr

23.9%

EPS NY

22.2%

52W%

5.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +360.8% upside

Quality

7/30

Valuation

16/30

Growth

14/25

Stability

7/10

LT Trend

3/5

Upside

+360.8%

Quality

ADCT — P/E HistoricalBiotechnology

ADC Therapeutics SA

Sector: Healthcare

Industry: Biotechnology

Employees: 188

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.

ADCT

Latest News

—

Caricamento notizie per ADCT…

stock quote shares ADCT – Adc Therapeutics SA Stock Price stock today

news today ADCT – Adc Therapeutics SA stock forecast ,stock prediction 2023 2024 2025

marketwatch ADCT – Adc Therapeutics SA yahoo finance google finance

stock history ADCT – Adc Therapeutics SA invest stock market

stock prices ADCT premarket after hours

ticker ADCT fair value insiders trading

CS – Credit Suisse Group AG

UBS – UBS Group AG

UBS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.27

Margin Of Safety %

Put/Call OI Ratio

1.3

EPS Next Q Diff

0.01

EPS Last/This Y

0.85

EPS This/Next Y

0.79

Price

49.12

Target Price

50.01

Analyst Recom

2.63

Performance Q

33.45

Upside

98.9%

Beta

1.17

Ticker: UBS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	UBS	47.1	1.29	0.60	89252
2026-06-02	UBS	48.16	1.28	0.25	90050
2026-06-03	UBS	47.34	1.27	0.72	91388
2026-06-04	UBS	47.68	1.28	0.30	91550
2026-06-05	UBS	47.01	1.28	3.74	91826
2026-06-08	UBS	47.3	1.32	1.36	93648
2026-06-09	UBS	47.86	1.32	0.82	93803
2026-06-10	UBS	46.76	1.32	2.25	93968
2026-06-11	UBS	48.2	1.33	1.94	94474
2026-06-12	UBS	48.96	1.33	0.29	94916
2026-06-15	UBS	49.55	1.33	1.23	94958
2026-06-16	UBS	50.45	1.35	0.25	95853
2026-06-17	UBS	49.72	1.32	0.28	97386
2026-06-18	UBS	50.8	1.31	0.38	98083
2026-06-22	UBS	51.13	1.30	1.12	91802
2026-06-23	UBS	50.29	1.31	0.55	93238
2026-06-24	UBS	49.41	1.30	2.20	93596
2026-06-25	UBS	49.94	1.31	0.82	93749
2026-06-26	UBS	49.1	1.30	1.56	94164
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	UBS	47.11	13.6	-	2.96
2026-06-01	UBS	48.00	13.6	-	3.26
2026-06-02	UBS	48.19	13.6	-	3.26
2026-06-03	UBS	47.32	13.6	-	3.26
2026-06-04	UBS	47.67	13.6	-	3.26
2026-06-05	UBS	46.99	13.6	-	3.26
2026-06-08	UBS	47.29	13.6	-	3.26
2026-06-09	UBS	47.85	13.6	-	3.26
2026-06-10	UBS	46.77	13.6	-	3.26
2026-06-11	UBS	48.21	13.6	-	3.26
2026-06-12	UBS	48.97	13.6	-	3.31
2026-06-15	UBS	49.55	13.6	-	3.31
2026-06-16	UBS	50.47	13.6	-	3.31
2026-06-17	UBS	49.71	13.6	-	3.31
2026-06-18	UBS	50.81	13.6	-	3.31
2026-06-22	UBS	51.13	13.6	-	3.31
2026-06-23	UBS	50.29	13.6	-	3.30
2026-06-24	UBS	49.40	13.6	-	3.30
2026-06-25	UBS	49.95	13.6	-	3.30
2026-06-26	UBS	49.12	13.6	-	3.31
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	UBS	0.00	-5.25	0.26
2026-06-02	UBS	0.00	-6.54	0.26
2026-06-03	UBS	0.00	-6.54	0.26
2026-06-04	UBS	0.00	-6.54	0.26
2026-06-05	UBS	0.00	-6.54	0.26
2026-06-08	UBS	0.00	-6.56	0.26
2026-06-09	UBS	0.00	-6.56	0.26
2026-06-10	UBS	0.00	-6.56	0.27
2026-06-11	UBS	0.00	-6.56	0.27
2026-06-12	UBS	0.00	-6.56	0.27
2026-06-15	UBS	0.00	-6.66	0.27
2026-06-16	UBS	0.00	-6.66	0.27
2026-06-17	UBS	0.00	-6.66	0.27
2026-06-18	UBS	0.00	-6.66	0.27
2026-06-22	UBS	0.00	-6.66	0.27
2026-06-23	UBS	0.00	-6.66	0.27
2026-06-24	UBS	0.00	-6.66	0.27
2026-06-25	UBS	0.00	-6.66	0.27
2026-06-26	UBS	0.00	-6.66	0.27
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.94

Avg. EPS Est. Current Quarter

0.93

Avg. EPS Est. Next Quarter

0.95

Insider Transactions

Institutional Transactions

-6.66

Beta

1.17

Average Sales Estimate Current Quarter

10318

Average Sales Estimate Next Quarter

10202

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

4.1

Max Drawdown 5-Year %

-32.5

Target Price

50.01

P/E

17.59

Forward P/E

11.96

PEG

0.62

P/S

1.87

P/B

1.65

P/Free Cash Flow

EPS

2.79

Average EPS Est. Cur. Y

3.31

EPS Next Y. (Est.)

4.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.44

Relative Volume

0.67

Return on Equity vs Sector %

-2

Return on Equity vs Industry %

-1.2

EPS 1 7Days Diff

EPS 1 30Days Diff

3.31

EBIT Estimation

◆ UBS Financial

$49.09

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

7/25

Volume

9/15

Valuation

4/20

TP/AR

0/10

Options

2/10

RSI

54.7

Range 1M

55.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

18/30

Estimates

2/20

Inst/Vol

4/15

Options

3/10

EPS Yr

25.3%

EPS NY

19.1%

52W%

88%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +137.4% upside

Quality

4/30

Valuation

19/30

Growth

15/25

Stability

1/10

LT Trend

1/5

Upside

+137.4%

Quality

UBS — P/E HistoricalBanks - Diversified

UBS Group AG Registered

Sector: Financial Services

Industry: Banks - Diversified

Employees: 101594

UBS Group AG operates as a wealth manager and bank worldwide. It operates through five segments: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-Core and Legacy. The Global Wealth Management segment offers financial services, advice, and solutions; investment management, estate planning, and corporate advice services; and wealth management and banking products and services to private wealth and institutional customers. Its Personal & Corporate Banking segment provides banking, retirement, financing, investments, and strategic transactions to private, corporate, and institutional customers through its branch network and digital channels in Switzerland. The Asset Management segment offers diversified asset management services. Its Investment Bank segment provides equities, foreign exchange, precious metals, research, advisory, and capital markets services to institutional, corporate, financial sponsor, and Global Wealth Management customers, as well as focused rates and credit platform. The company also offers lending products, such as securities-based lending, mortgages, structured products, and tailored solutions; collateralized lending residential and commercial real estate, primarily against securities, residential and commercial real estate, other real assets (such as ships and aircraft), private market and hedge fund interest; and unsecured lending. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.

UBS

Latest News

—

Caricamento notizie per UBS…

stock quote shares UBS – UBS Group AG Stock Price stock today

news today UBS – UBS Group AG stock forecast ,stock prediction 2023 2024 2025

marketwatch UBS – UBS Group AG yahoo finance google finance

stock history UBS – UBS Group AG invest stock market

stock prices UBS premarket after hours

ticker UBS fair value insiders trading

STM – STMicroelectronics N.V.

STM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.27

Margin Of Safety %

Put/Call OI Ratio

0.65

EPS Next Q Diff

0.31

EPS Last/This Y

1.09

EPS This/Next Y

1.23

Price

71.4

Target Price

73.01

Analyst Recom

Performance Q

117.02

Upside

-92.6%

Beta

1.91

Ticker: STM

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-29	STM	69.3	0.46	0.39	327645
2026-06-02	STM	79.5	0.53	0.17	320691
2026-06-03	STM	80.7	0.50	0.12	355545
2026-06-04	STM	78.36	0.50	0.44	353744
2026-06-05	STM	70.51	0.52	0.04	354496
2026-06-08	STM	74.94	0.54	0.07	341406
2026-06-09	STM	73.4	0.52	0.23	352677
2026-06-10	STM	70.75	0.52	0.08	355143
2026-06-11	STM	77.93	0.52	0.37	358386
2026-06-12	STM	77.27	0.52	0.13	372592
2026-06-15	STM	78.95	0.53	0.35	364207
2026-06-16	STM	74.36	0.55	0.21	376350
2026-06-17	STM	74.57	0.54	0.47	385267
2026-06-18	STM	78.34	0.55	0.19	408913
2026-06-22	STM	79.84	0.65	0.36	289075
2026-06-23	STM	72.55	0.66	0.35	292797
2026-06-24	STM	71.98	0.65	0.23	299110
2026-06-25	STM	75.09	0.67	0.54	297936
2026-06-26	STM	71.23	0.65	0.15	299537
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-29	STM	69.29	312.6	637.4	1.08
2026-06-01	STM	69.02	312.6	640.0	1.08
2026-06-02	STM	79.57	312.6	814.8	1.08
2026-06-03	STM	79.71	312.6	638.8	1.08
2026-06-04	STM	78.28	312.6	616.3	1.08
2026-06-05	STM	70.60	312.6	821.8	1.08
2026-06-08	STM	74.92	343.7	1108.6	1.27
2026-06-09	STM	73.36	343.7	1027.5	1.27
2026-06-10	STM	70.74	343.7	1064.0	1.27
2026-06-11	STM	78.09	343.7	1229.1	1.27
2026-06-12	STM	77.26	343.7	1117.3	1.27
2026-06-15	STM	78.96	343.7	1077.2	1.27
2026-06-16	STM	74.59	343.7	973.1	1.27
2026-06-17	STM	73.37	343.7	1011.1	1.27
2026-06-18	STM	78.43	343.7	1123.3	1.27
2026-06-22	STM	79.89	343.7	1101.5	1.27
2026-06-23	STM	72.43	343.7	930.8	1.27
2026-06-24	STM	71.94	343.7	1056.4	1.27
2026-06-25	STM	74.88	343.7	1129.5	1.27
2026-06-26	STM	71.40	343.7	1017.1	1.28
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-29	STM	0	4.32	1.55
2026-06-02	STM	0	2.92	1.55
2026-06-03	STM	0	2.92	1.55
2026-06-04	STM	0	2.92	1.55
2026-06-05	STM	0	2.92	1.55
2026-06-08	STM	0	2.47	1.55
2026-06-09	STM	0	2.47	1.55
2026-06-10	STM	0	2.47	1.40
2026-06-11	STM	0	2.47	1.40
2026-06-12	STM	0	2.47	1.40
2026-06-15	STM	0	3.06	1.40
2026-06-16	STM	0	3.06	1.40
2026-06-17	STM	0	3.06	1.40
2026-06-18	STM	0	3.06	1.40
2026-06-22	STM	0	3.27	1.40
2026-06-23	STM	0.00	3.27	1.40
2026-06-24	STM	0.00	3.27	1.40
2026-06-25	STM	0.00	3.27	1.40
2026-06-26	STM	0.00	3.27	1.27
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.13

Avg. EPS Est. Current Quarter

0.27

Avg. EPS Est. Next Quarter

0.44

Insider Transactions

Institutional Transactions

3.27

Beta

1.91

Average Sales Estimate Current Quarter

3458

Average Sales Estimate Next Quarter

3780

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

12.3

Max Drawdown 5-Year %

-66.7

Target Price

73.01

P/E

464.37

Forward P/E

27.87

PEG

0.31

P/S

5.12

P/B

3.57

P/Free Cash Flow

395.25

EPS

0.15

Average EPS Est. Cur. Y

1.28

EPS Next Y. (Est.)

2.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.17

Relative Volume

0.81

Return on Equity vs Sector %

-53.6

Return on Equity vs Industry %

-56.6

EPS 1 7Days Diff

1.3

EPS 1 30Days Diff

1.28

EBIT Estimation

1017.1

◆ STM Technology

$71.42

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

9/25

Volume

7/15

Valuation

7/20

TP/AR

5/10

Options

4/10

RSI

50.4

Range 1M

33.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

21/30

Estimates

10/20

Inst/Vol

8/15

Options

5/10

EPS Yr

141.2%

EPS NY

100.5%

52W%

83%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +16.7% upside

Quality

5/30

Valuation

9/30

Growth

17/25

Stability

6/10

LT Trend

0/5

Upside

+16.7%

Quality

STM — P/E HistoricalSemiconductors

STMicroelectronics N.V.

Sector: Technology

Industry: Semiconductors

Employees: 48000

STMicroelectronics N.V., together with its subsidiaries, designs, develops, manufactures, and sells semiconductor products in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates through Analog products, MEMS and Sensors Group (AM&S); Power and Discrete products (P&D); Embedded Processing (EMP); and RF Products (D&RF) segments. It offers industrial application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs); power management solutions; custom analog ICs, wireless charging solutions; galvanic isolated gate and LED drivers; converters, transistors, intelligent power switches, clocks and timers, comparators, and current-sense amplifiers; micro-electro-mechanical systems (MEMS) sensors, including accelerometers, gyroscopes, magnetic sensors, pressure, temperature, presence detection, biosensors, machine learning, and edge AI processing smart sensors, as well as thermal and piezoelectric actuators; and optical sensing solutions. The company also provides silicon MOSFETs, SiC MOSFETs, IGBTs, thyristors, rectifiers, and power modules and bipolar transistors; microcontrollers, and automotive microcontrollers and secured; radio frequency (RF) communications and ASICs; car infotainment products; ultra-wide band and radar systems; and Connected Security Products; and automotive driver assistance systems. It serves automotive, industrial, personal electronics and communications equipment, and computers and peripherals markets. STMicroelectronics N.V. was incorporated in 1987 and is headquartered in Schiphol, the Netherlands.

STM

Latest News

—

Caricamento notizie per STM…

stock quote shares STM – STMicroelectronics N.V. Stock Price stock today

news today STM – STMicroelectronics N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch STM – STMicroelectronics N.V. yahoo finance google finance

stock history STM – STMicroelectronics N.V. invest stock market

stock prices STM premarket after hours

ticker STM fair value insiders trading

No more stocks to show

ONC – BeOne Medicines Ltd ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ONC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

AMRZ – Amrize Ltd

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AMRZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y